Fifty percent or more of that risk heterogeneity was found to be attributable to genetic ancestry differences, suggesting that although APOE is still an important locus for AD risk across populations, the strength of the effect of APOE on AD risk varies with genetic ancestral background.6 This evidence concerns the gene APOE and Alzheimer disease.